{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T14:27:31Z","timestamp":1787149651586,"version":"build-2736575974"},"publisher-location":"Basel","reference-count":148,"publisher":"Springer Basel","isbn-type":[{"value":"9783764383398","type":"print"},{"value":"9783764383404","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-7643-8340-4_9","type":"book-chapter","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T07:05:53Z","timestamp":1338966353000},"page":"251-287","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunotoxicology and Its Application in Risk Assessment"],"prefix":"10.1007","author":[{"given":"Andrew A.","family":"Rooney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Luebke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MaryJane K.","family":"Selgrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dori R.","family":"Germolec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,24]]},"reference":[{"key":"9_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15287390500194326","volume":"9","author":"RW Luebke","year":"2006","unstructured":"Luebke RW, Chen D, Dietert R, Yang Y, King M, Luster M (2006) The comparative immunotoxicity of five selected compounds following developmental or adult exposure. J Toxicol Environ Health B Crit Rev 9:1\u201326","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"9_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0378-4274(02)00490-3","volume":"140\u2013141","author":"J Descotes","year":"2003","unstructured":"Descotes J (2003) From clinical to human toxicology: linking animal research and risk assessment in man. Toxicol Lett 140\u2013141:3\u201310","journal-title":"Toxicol Lett"},{"key":"9_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0300-483X(98)00059-6","volume":"129","author":"JG Vos","year":"1998","unstructured":"Vos JG, Van Loveren H (1998) Experimental studies on immunosuppression: how do they predict for man? Toxicology 129:13\u201326","journal-title":"Toxicology"},{"key":"9_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.yrtph.2007.11.008","volume":"50","author":"H van Loveren","year":"2008","unstructured":"van Loveren H, Cockshott A, Gebel T, Gundert-Remy U, de Jong WH, Matheson J, McGarry H, Musset L, Selgrade MK, Vickers C (2008) Skin sensitization in chemical risk assessment: report of a WHO\/IPCS international workshop focusing on dose-response assessment. Regul Toxicol Pharmacol 50:155\u2013199","journal-title":"Regul Toxicol Pharmacol"},{"key":"9_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ymeth.2006.07.006","volume":"41","author":"FG Gerberick","year":"2007","unstructured":"Gerberick FG, Ryan CA, Dearman RJ, Kimber I (2007) Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. Methods 41:54\u201360","journal-title":"Methods"},{"key":"9_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/S0278-6915(01)00130-2","volume":"40","author":"DA Basketter","year":"2002","unstructured":"Basketter DA, Evans P, Fielder RJ, Gerberick GF, Dearman RJ, Kimber I (2002) Local lymph node assay\u2015validation, conduct and use in practice. Food Chem Toxicol 40:593\u2013598","journal-title":"Food Chem Toxicol"},{"key":"9_CR7","series-title":"IPCS environmental health criteria 236. International programme on chemical safety","volume-title":"Principles and methods for assessing autoimmunity associated with exposure to chemicals","author":"WHO","year":"2006","unstructured":"WHO (2006) Principles and methods for assessing autoimmunity associated with exposure to chemicals, IPCS environmental health criteria 236. International programme on chemical safety. World Health Organization, Geneva, Switzerland"},{"key":"9_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/toxsci\/kfm244","volume":"100","author":"MK Selgrade","year":"2007","unstructured":"Selgrade MK (2007) Immunotoxicity: the risk is real. Toxicol Sci 100:328\u2013332","journal-title":"Toxicol Sci"},{"key":"9_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0300-483X(00)00434-0","volume":"160","author":"LD Koller","year":"2001","unstructured":"Koller LD (2001) A perspective on the progression of immunotoxicology. Toxicology 160:105\u2013110","journal-title":"Toxicology"},{"key":"9_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/15476910490438342","volume":"1","author":"RW Luebke","year":"2004","unstructured":"Luebke RW, Parks C, Luster MI (2004) Suppression of immune function and susceptibility to infections in humans: association of immune function with clinical disease. J Immunotoxicol 1:15\u201324","journal-title":"J Immunotoxicol"},{"key":"9_CR11","volume-title":"Current protocols in toxicology","author":"MI Luster","year":"2004","unstructured":"Luster MI, Blanciforti LM, Germolec DR, Parks C, Kashon M, Luebke R (2004) Associating changes in the immune system with clinical diseases for interpretation in risk assessment. In: Maines M, Costa L, Reed D, Hodgson E (eds) Current protocols in toxicology. Wiley, New York, NY"},{"key":"9_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15476910802483324","volume":"5","author":"RR Dietert","year":"2008","unstructured":"Dietert RR (2008) Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment. J Immunotoxicol 5:401\u2013412","journal-title":"J Immunotoxicol"},{"key":"9_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1289\/ehp.01109757","volume":"109","author":"H Van Loveren","year":"2001","unstructured":"Van Loveren H, Van Amsterdam JG, Vandebriel RJ, Kimman TG, Rumke HC, Steerenberg PS, Vos JG (2001) Vaccine-induced antibody responses as parameters of the influence of endogenous and environmental factors. Environ Health Perspect 109:757\u2013764","journal-title":"Environ Health Perspect"},{"key":"9_CR14","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1016\/S0264-410X(03)00341-4","volume":"21","author":"H Gans","year":"2003","unstructured":"Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM (2003) Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 21:3398\u20133405","journal-title":"Vaccine"},{"key":"9_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/135475099230949","volume":"4","author":"H Van Loveren","year":"1999","unstructured":"Van Loveren H, Germolec D, Koren H, Luster M, Nolan C, Repetto R, Smith E, Vos JG, Vogt R (1999) Report of the Bilthoven symposium: advancement of epidemiological studies in assessing the human health effects of immunotoxic agents in the environment and the workplace. Biomarkers 4:135\u2013157","journal-title":"Biomarkers"},{"key":"9_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0272-0590(92)90047-L","volume":"18","author":"MI Luster","year":"1992","unstructured":"Luster MI, Portier C, Pait DG, White KL Jr, Gennings C, Munson AE, Rosenthal GJ (1992) Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Fundam Appl Toxicol 18:200\u2013210","journal-title":"Fundam Appl Toxicol"},{"key":"9_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1006\/faat.1993.1074","volume":"21","author":"MI Luster","year":"1993","unstructured":"Luster MI, Portier C, Pait DG, Rosenthal GJ, Germolec DR, Corsini E, Blaylock BL, Pollock P, Kouchi Y, Craig W, White KL, Munson AE, Comment CE (1993) Risk assessment in immunotoxicology. II. Relationships between immune and host resistance tests. Fundam Appl Toxicol 21:71\u201382","journal-title":"Fundam Appl Toxicol"},{"key":"9_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0753-3322(00)80066-9","volume":"54","author":"EV Yang","year":"2000","unstructured":"Yang EV, Glaser R (2000) Stress-induced immunomodulation: impact on immune defenses against infectious disease. Biomed Pharmacother 54:245\u2013250","journal-title":"Biomed Pharmacother"},{"key":"9_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1037\/0278-6133.12.6.435","volume":"12","author":"R Glaser","year":"1993","unstructured":"Glaser R, Pearson GR, Bonneau RH, Esterling BA, Atkinson C, Kiecolt-Glaser JK (1993) Stress and the memory T-cell response to the Epstein\u2013Barr virus in healthy medical students. Health Psychol 12:435\u2013442","journal-title":"Health Psychol"},{"key":"9_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0889-1591(87)90002-X","volume":"1","author":"R Glaser","year":"1987","unstructured":"Glaser R, Rice J, Sheridan J, Fertel R, Stout J, Speicher C, Pinsky D, Kotur M, Post A, Beck M (1987) Stress-related immune suppression: health implications. Brain Behav Immun 1:7\u201320","journal-title":"Brain Behav Immun"},{"key":"9_CR21","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1037\/0278-6133.12.2.132","volume":"12","author":"BA Esterling","year":"1993","unstructured":"Esterling BA, Antoni MH, Kumar M, Schneiderman N (1993) Defensiveness, trait anxiety, and Epstein\u2013Barr viral capsid antigen antibody titers in healthy college students. Health Psychol 12:132\u2013139","journal-title":"Health Psychol"},{"key":"9_CR22","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S53","volume":"152","author":"S Cohen","year":"1995","unstructured":"Cohen S (1995) Psychological stress and susceptibility to upper respiratory infections. Am J Respir Crit Care Med 152:S53\u2013S58","journal-title":"Am J Respir Crit Care Med"},{"key":"9_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000289101","volume":"66","author":"M Biondi","year":"1997","unstructured":"Biondi M, Zannino LG (1997) Psychological stress, neuroimmunomodulation, and susceptibility to infectious diseases in animals and man: a review. Psychother Psychosom 66:3\u201326","journal-title":"Psychother Psychosom"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006842-197910000-00002","volume":"41","author":"SV Kasl","year":"1979","unstructured":"Kasl SV, Evans AS, Niederman JC (1979) Psychosocial risk factors in the developmental of infectious mononucleosis. Psychosom Med 41:445\u2013466","journal-title":"Psychosom Med"},{"key":"9_CR25","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1056\/NEJM199108293250903","volume":"325","author":"S Cohen","year":"1991","unstructured":"Cohen S, Tyrrell DA, Smith AP (1991) Psychological stress and susceptibility to the common cold. N Engl J Med 325:606\u2013612","journal-title":"N Engl J Med"},{"key":"9_CR26","series-title":"IPCS environmental health criteria 180. International programme on chemical safety","volume-title":"Principles and methods for assessing direct immunotoxicity associated with exposure to chemicals","author":"WHO","year":"1996","unstructured":"WHO (1996) Principles and methods for assessing direct immunotoxicity associated with exposure to chemicals, IPCS environmental health criteria 180. International programme on chemical safety. World Health Organization, Geneva, Switzerland"},{"key":"9_CR27","volume-title":"Guidance for industry: immunotoxicity testing guidance. Report","author":"U.S. FDA","year":"1999","unstructured":"U.S. FDA (1999) Guidance for industry: immunotoxicity testing guidance. Report. Center for Devices and Radiological Health, Rockville, MD"},{"key":"9_CR28","volume-title":"Guidance for industry: immunotoxicity evaluation of investigational new drugs. Report","author":"U.S. FDA","year":"2002","unstructured":"U.S. FDA (2002) Guidance for industry: immunotoxicity evaluation of investigational new drugs. Report. Center for Drug Evaluation and Research, Rockville, MD"},{"key":"9_CR29","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1001\/archderm.140.6.723","volume":"140","author":"AN Lee","year":"2004","unstructured":"Lee AN, Werth VP (2004) Activation of autoimmunity following use of immunostimulatory herbal supplements. Arch Dermatol 140:723\u2013727","journal-title":"Arch Dermatol"},{"key":"9_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.autrev.2006.09.012","volume":"6","author":"B Holvast","year":"2007","unstructured":"Holvast B, Huckriede A, Kallenberg CG, Bijl M (2007) Influenza vaccination in systemic lupus erythematosus: safe and protective? Autoimmun Rev 6:300\u2013305","journal-title":"Autoimmun Rev"},{"key":"9_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.autrev.2006.09.005","volume":"6","author":"O Elkayam","year":"2007","unstructured":"Elkayam O, Ablin J, Caspi D (2007) Safety and efficacy of vaccination against Streptococcus pneumonia in patients with rheumatic diseases. Autoimmun Rev 6:312\u2013314","journal-title":"Autoimmun Rev"},{"key":"9_CR32","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/587063","volume":"46","author":"T Gluck","year":"2008","unstructured":"Gluck T, Muller-Ladner U (2008) Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 46:1459\u20131465","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"9_CR33","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1289\/ehp.99107s5793","volume":"107","author":"CG Parks","year":"1999","unstructured":"Parks CG, Conrad K, Cooper GS (1999) Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect 107(Suppl 5):793\u2013802","journal-title":"Environ Health Perspect"},{"issue":"Suppl 1","key":"9_CR34","first-page":"25","volume":"27","author":"I Sterzl","year":"2006","unstructured":"Sterzl I, Prochazkova J, Hrda P, Matucha P, Bartova J, Stejskal V (2006) Removal of dental amalgam decreases anti-TPO and anti-Tg autoantibodies in patients with autoimmune thyroiditis. Neuro Endocrinol Lett 27(Suppl 1):25\u201330","journal-title":"Neuro Endocrinol Lett"},{"key":"9_CR35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1164\/ajrccm.160.1.9807104","volume":"160","author":"DR Gold","year":"1999","unstructured":"Gold DR, Burge HA, Carey V, Milton DK, Platts-Mills T, Weiss ST (1999) Predictors of repeated wheeze in the first year of life: the relative roles of cockroach, birth weight, acute lower respiratory illness, and maternal smoking. Am J Respir Crit Care Med 160:227\u2013236","journal-title":"Am J Respir Crit Care Med"},{"key":"9_CR36","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2105\/AJPH.94.1.136","volume":"94","author":"JJ Jaakkola","year":"2004","unstructured":"Jaakkola JJ, Gissler M (2004) Maternal smoking in pregnancy, fetal development, and childhood asthma. Am J Public Health 94:136\u2013140","journal-title":"Am J Public Health"},{"key":"9_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/toxsci\/kfj006","volume":"89","author":"SP Ng","year":"2006","unstructured":"Ng SP, Silverstone AE, Lai ZW, Zelikoff JT (2006) Effects of prenatal exposure to cigarette smoke on offspring tumor susceptibility and associated immune mechanisms. Toxicol Sci 89:135\u2013144","journal-title":"Toxicol Sci"},{"key":"9_CR38","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1289\/ehp.001081203","volume":"108","author":"N Weisglas-Kuperus","year":"2000","unstructured":"Weisglas-Kuperus N, Patandin S, Berbers GA, Sas TC, Mulder PG, Sauer PJ, Hooijkaas H (2000) Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect 108:1203\u20131207","journal-title":"Environ Health Perspect"},{"key":"9_CR39","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1371\/journal.pmed.0030311","volume":"3","author":"C Heilmann","year":"2006","unstructured":"Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jorgensen E (2006) Reduced antibody responses to vaccinations in children exposed to polychlorinated biphenyls. PLoS Med 3:1352\u20131359","journal-title":"PLoS Med"},{"key":"9_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1289\/ehp.8683","volume":"114","author":"F Dallaire","year":"2006","unstructured":"Dallaire F, Dewailly E, Vezina C, Muckle G, Weber JP, Bruneau S, Ayotte P (2006) Effect of prenatal exposure to polychlorinated biphenyls on incidence of acute respiratory infections in preschool Inuit children. Environ Health Perspect 114:1301\u20131305","journal-title":"Environ Health Perspect"},{"issue":"Suppl 3","key":"9_CR41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/08958378.2000.11463248","volume":"12","author":"MI Gilmour","year":"2000","unstructured":"Gilmour MI, Selgrade MJK, Lambert AL (2000) Enhanced allergic sensitization in animals exposed to particulate air pollution. Inhal Toxicol 12(Suppl 3):373\u2013380","journal-title":"Inhal Toxicol"},{"key":"9_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/08958370590904490","volume":"17","author":"PA Steerenberg","year":"2005","unstructured":"Steerenberg PA, Withagen CE, van Dalen WJ, Dormans JA, Heisterkamp SH, van Loveren H, Cassee FR (2005) Dose dependency of adjuvant activity of particulate matter from five European sites in three seasons in an ovalbumin-mouse model. Inhal Toxicol 17:133\u2013145","journal-title":"Inhal Toxicol"},{"key":"9_CR43","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1289\/ehp.8380","volume":"114","author":"MI Gilmour","year":"2006","unstructured":"Gilmour MI, Jaakkola MS, London SJ, Nel AE, Rogers CA (2006) How exposure to environmental tobacco smoke, outdoor air pollutants, and increased pollen burdens influences the incidence of asthma. Environ Health Perspect 114:627\u2013633","journal-title":"Environ Health Perspect"},{"key":"9_CR44","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0272-0590(88)90280-1","volume":"11","author":"MK Selgrade","year":"1988","unstructured":"Selgrade MK, Illing JW, Starnes DM, Stead AG, Menache MG, Stevens MA (1988) Evaluation of effects of ozone exposure on influenza infection in mice using several indicators of susceptibility. Fundam Appl Toxicol 11:169\u2013180","journal-title":"Fundam Appl Toxicol"},{"key":"9_CR45","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfm282","volume":"102","author":"S Teske","year":"2008","unstructured":"Teske S, Bohn AA, Hogaboam JP, Lawrence BP (2008) Aryl hydrocarbon receptor targets pathways extrinsic to bone marrow cells to enhance neutrophil recruitment during influenza virus infection. Toxicol Sci 102:89\u201399","journal-title":"Toxicol Sci"},{"key":"9_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/toxsci\/69.1.109","volume":"69","author":"RW Luebke","year":"2002","unstructured":"Luebke RW, Copeland CB, Bishop LR, Daniels MJ, Gilmour MI (2002) Mortality in dioxin-exposed mice infected with influenza: mitochondrial toxicity (reye\u2019s-like syndrome) versus enhanced inflammation as the mode of action. Toxicol Sci 69:109\u2013116","journal-title":"Toxicol Sci"},{"key":"9_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/toxsci\/67.1.88","volume":"67","author":"LK Ryan","year":"2002","unstructured":"Ryan LK, Copeland LR, Daniels MJ, Costa ER, Selgrade MJ (2002) Proinflammatory and Th1 cytokine alterations following ultraviolet radiation enhancement of disease due to influenza infection in mice. Toxicol Sci 67:88\u201397","journal-title":"Toxicol Sci"},{"key":"9_CR48","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1080\/15287390306456","volume":"66","author":"CA Hudson","year":"2003","unstructured":"Hudson CA, Cao L, Kasten-Jolly J, Kirkwood JN, Lawrence DA (2003) Susceptibility of lupus-prone NZM mouse strains to lead exacerbation of systemic lupus erythematosus symptoms. J Toxicol Environ Health A 66:895\u2013918","journal-title":"J Toxicol Environ Health A"},{"key":"9_CR49","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0162-3109(86)90003-2","volume":"12","author":"KE Rodgers","year":"1986","unstructured":"Rodgers KE, Imamura T, Devens BH (1986) Organophosphorus pesticide immunotoxicity: effects of O,O,S-trimethyl phosphorothioate on cellular and humoral immune response systems. Immunopharmacology 12:193\u2013202","journal-title":"Immunopharmacology"},{"key":"9_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1006\/jaut.1997.0145","volume":"10","author":"KE Rodgers","year":"1997","unstructured":"Rodgers KE (1997) Effects of oral administration of malathion on the course of disease in MRL-lpr mice. J Autoimmun 10:367\u2013373","journal-title":"J Autoimmun"},{"key":"9_CR51","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/9780470285251.ch32","volume-title":"Molecular and biochemical toxicology","author":"MJK Selgrade","year":"2008","unstructured":"Selgrade MJK, Germolec DR, Luebke RW, Smialowicz RJ, Ward MD, Bowman CB (2008) Immunotoxicology. In: Smart RC, Hodgson E (eds) Molecular and biochemical toxicology. Wiley, Hoboken, NJ, pp 765\u2013803"},{"issue":"Suppl","key":"9_CR52","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1007\/s00420-002-0345-1","volume":"75","author":"DB Kirchner","year":"2002","unstructured":"Kirchner DB (2002) The spectrum of allergic disease in the chemical industry. Int Arch Occup Environ Health 75(Suppl):S107\u2013112","journal-title":"Int Arch Occup Environ Health"},{"key":"9_CR53","first-page":"52","volume":"18","author":"R Treudler","year":"2008","unstructured":"Treudler R, Kozovska Y, Simon JC (2008) Severe immediate type hypersensitivity reactions in 105 German adults: when to diagnose anaphylaxis. J Investig Allergol Clin Immunol 18:52\u201358","journal-title":"J Investig Allergol Clin Immunol"},{"key":"9_CR54","series-title":"IPCS environmental health criteria 212. International programme on chemical safety","volume-title":"Principles and methods for assessing allergic hypersensitization associated with exposure to chemicals","author":"WHO","year":"1999","unstructured":"WHO (1999) Principles and methods for assessing allergic hypersensitization associated with exposure to chemicals, IPCS environmental health criteria 212. International programme on chemical safety. World Health Organization, Geneva, Switzerland"},{"key":"9_CR55","first-page":"709","volume":"53","author":"PS Friedmann","year":"1983","unstructured":"Friedmann PS, Moss C, Shuster S, Simpson JM (1983) Quantitative relationships between sensitizing dose of DNCB and reactivity in normal subjects. Clin Exp Immunol 53:709\u2013715","journal-title":"Clin Exp Immunol"},{"key":"9_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1006\/taap.2002.9469","volume":"183","author":"AE Scott","year":"2002","unstructured":"Scott AE, Kashon ML, Yucesoy B, Luster MI, Tinkle SS (2002) Insights into the quantitative relationship between sensitization and challenge for allergic contact dermatitis reactions. Toxicol Appl Pharmacol 183:66\u201370","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR57","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/j.1365-2133.2007.08162.x","volume":"157","author":"PS Friedmann","year":"2007","unstructured":"Friedmann PS (2007) The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans. Br J Dermatol 157:1093\u20131102","journal-title":"Br J Dermatol"},{"key":"9_CR58","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00420-002-0420-7","volume":"76","author":"KE Andersen","year":"2003","unstructured":"Andersen KE (2003) Occupational issues of allergic contact dermatitis. Int Arch Occup Environ Health 76:347\u2013350","journal-title":"Int Arch Occup Environ Health"},{"key":"9_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yrtph.2007.10.019","volume":"52","author":"PM McNamee","year":"2008","unstructured":"McNamee PM, Api AM, Basketter DA, Frank Gerberick G, Gilpin DA, Hall BM, Jowsey I, Robinson MK (2008) A review of critical factors in the conduct and interpretation of the human repeat insult patch test. Regul Toxicol Pharmacol 52:24\u201334","journal-title":"Regul Toxicol Pharmacol"},{"key":"9_CR60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/jid.1966.160","volume":"47","author":"AM Kligman","year":"1966","unstructured":"Kligman AM (1966) The identification of contact allergens by human assay. 3. The maximization test: a procedure for screening and rating contact sensitizers. J Invest Dermatol 47:393\u2013409","journal-title":"J Invest Dermatol"},{"key":"9_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.yrtph.2007.11.004","volume":"52","author":"VT Politano","year":"2008","unstructured":"Politano VT, Api AM (2008) The research institute for fragrance materials\u2019 human repeated insult patch test protocol. Regul Toxicol Pharmacol 52:35\u201338","journal-title":"Regul Toxicol Pharmacol"},{"key":"9_CR62","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1001\/archderm.1965.01600080079017","volume":"91","author":"EV Buehler","year":"1965","unstructured":"Buehler EV (1965) Delayed contact hypersensitivity in the guinea pig. Arch Dermatol 91:171\u2013177","journal-title":"Arch Dermatol"},{"key":"9_CR63","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/jid.1969.42","volume":"52","author":"B Magnusson","year":"1969","unstructured":"Magnusson B, Kligman AM (1969) The identification of contact allergens by animal assay. The guinea pig maximization test. J Invest Dermatol 52:268\u2013276","journal-title":"J Invest Dermatol"},{"key":"9_CR64","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1034\/j.1600-0536.2002.470601.x","volume":"47","author":"I Kimber","year":"2002","unstructured":"Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF (2002) The local lymph node assay: past, present and future. Contact Dermatits 47:315\u2013328","journal-title":"Contact Dermatits"},{"key":"9_CR66","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1006\/rtph.2001.1497","volume":"34","author":"JH Dean","year":"2001","unstructured":"Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, Stokes WS (2001) ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel. Regul Toxicol Pharmacol 34:258\u2013273","journal-title":"Regul Toxicol Pharmacol"},{"key":"9_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.yrtph.2007.10.008","volume":"52","author":"AM Api","year":"2008","unstructured":"Api AM, Basketter DA, Cadby PA, Cano MF, Ellis G, Gerberick GF, Griem P, McNamee PM, Ryan CA, Safford R (2008) Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regul Toxicol Pharmacol 52:3\u201323","journal-title":"Regul Toxicol Pharmacol"},{"key":"9_CR68","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.yrtph.2003.07.001","volume":"38","author":"P Griem","year":"2003","unstructured":"Griem P, Goebel C, Scheffler H (2003) Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data. Regul Toxicol Pharmacol 38:269\u2013290","journal-title":"Regul Toxicol Pharmacol"},{"key":"9_CR69","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yrtph.2004.02.002","volume":"39","author":"K Schneider","year":"2004","unstructured":"Schneider K, Akkan Z (2004) Quantitative relationship between the local lymph node assay and human skin sensitization assays. Regul Toxicol Pharmacol 39:245\u2013255","journal-title":"Regul Toxicol Pharmacol"},{"key":"9_CR70","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.155.7.3530","volume":"155","author":"C Anderson","year":"1995","unstructured":"Anderson C, Hehr A, Robbins R, Hasan R, Athar M, Mukhtar H, Elmets CA (1995) Metabolic requirements for induction of contact hypersensitivity to immunotoxic polyaromatic hydrocarbons. J Immunol 155:3530\u20133537","journal-title":"J Immunol"},{"key":"9_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0300-483X(01)00425-5","volume":"167","author":"FM van Och","year":"2001","unstructured":"van Och FM, Vandebriel RJ, Prinsen MK, De Jong WH, Slob W, van Loveren H (2001) Comparison of dose-responses of contact allergens using the guinea pig maximization test and the local lymph node assay. Toxicology 167:207\u2013215","journal-title":"Toxicology"},{"key":"9_CR72","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tox.2005.02.014","volume":"211","author":"T Yamano","year":"2005","unstructured":"Yamano T, Shimizu M, Noda T (2005) Quantitative comparison of the results obtained by the multiple-dose guinea pig maximization test and the non-radioactive murine local lymph-node assay for various biocides. Toxicology 211:165\u2013175","journal-title":"Toxicology"},{"key":"9_CR73","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/toxsci\/59.2.198","volume":"59","author":"I Kimber","year":"2001","unstructured":"Kimber I, Basketter DA, Berthold K, Butler M, Garrigue JL, Lea L, Newsome C, Roggeband R, Steiling W, Stropp G, Waterman S, Wiemann C (2001) Skin sensitization testing in potency and risk assessment. Toxicol Sci 59:198\u2013208","journal-title":"Toxicol Sci"},{"key":"9_CR74","first-page":"506","volume":"12","author":"SA Devos","year":"2002","unstructured":"Devos SA, Van Der Valk PG (2002) Epicutaneous patch testing. Eur J Dermatol 12:506\u2013513","journal-title":"Eur J Dermatol"},{"key":"9_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1600-0536.2000.043001001.x","volume":"43","author":"T Nakada","year":"2000","unstructured":"Nakada T, Hostynek JJ, Maibach HI (2000) Use tests: ROAT (repeated open application test)\/PUT (provocative use test): an overview. Contact Dermatits 43:1\u20133","journal-title":"Contact Dermatits"},{"key":"9_CR76","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1600-0536.2009.01607.x","volume":"61","author":"LA Fischer","year":"2009","unstructured":"Fischer LA, Voelund A, Andersen KE, Menne T, Johansen JD (2009) The dose-response relationship between the patch test and ROAT and the potential use for regulatory purposes. Contact Dermatits 61:201\u2013208","journal-title":"Contact Dermatits"},{"key":"9_CR77","first-page":"1","volume":"56","author":"JE Moorman","year":"2007","unstructured":"Moorman JE, Rudd RA, Johnson CA, King M, Minor P, Bailey C, Scalia MR, Akinbami LJ (2007) National surveillance for asthma\u2015United States, 1980-2004. MMWR Surveill Summ 56:1\u201354","journal-title":"MMWR Surveill Summ"},{"key":"9_CR78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.prrv.2004.11.001","volume":"6","author":"FH Sennhauser","year":"2005","unstructured":"Sennhauser FH, Braun-Fahrlander C, Wildhaber JH (2005) The burden of asthma in children: a European perspective. Paediatr Respir Rev 6:2\u20137","journal-title":"Paediatr Respir Rev"},{"issue":"Suppl 4","key":"9_CR79","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1289\/ehp.02110s4569","volume":"110","author":"EL Petsonk","year":"2002","unstructured":"Petsonk EL (2002) Work-related asthma and implications for the general public. Environ Health Perspect 110(Suppl 4):569\u2013572","journal-title":"Environ Health Perspect"},{"key":"9_CR80","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/10408440500534149","volume":"36","author":"JH Arts","year":"2006","unstructured":"Arts JH, Mommers C, de Heer C (2006) Dose-response relationships and threshold levels in skin and respiratory allergy. Crit Rev Toxicol 36:219\u2013251","journal-title":"Crit Rev Toxicol"},{"key":"9_CR81","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0091-6749(00)90089-7","volume":"105","author":"R Merget","year":"2000","unstructured":"Merget R, Kulzer R, Dierkes-Globisch A, Breitstadt R, Gebler A, Kniffka A, Artelt S, Koenig HP, Alt F, Vormberg R, Baur X, Schultze-Werninghaus G (2000) Exposure-effect relationship of platinum salt allergy in a catalyst production plant: conclusions from a 5-year prospective cohort study. J Allergy Clin Immunol 105:364\u2013370","journal-title":"J Allergy Clin Immunol"},{"key":"9_CR82","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3109\/08958370903380712","volume":"22","author":"YJ Chung","year":"2010","unstructured":"Chung YJ, Copeland LB, Doerfler DL, Ward MD (2010) The relative allergenicity of Stachybotrys chartarum compared to house dust mite extracts in a mouse model. Inhal Toxicol 22:460\u2013468","journal-title":"Inhal Toxicol"},{"key":"9_CR83","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00130832-200204000-00003","volume":"2","author":"K Sarlo","year":"2002","unstructured":"Sarlo K, Kirchner DB (2002) Occupational asthma and allergy in the detergent industry: new developments. Curr Opin Allergy Clin Immunol 2:97\u2013101","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9_CR84","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1046\/j.1365-2222.2000.00893.x","volume":"30","author":"MK Schweigert","year":"2000","unstructured":"Schweigert MK, Mackenzie DP, Sarlo K (2000) Occupational asthma and allergy associated with the use of enzymes in the detergent industry\u2015a review of the epidemiology, toxicology and methods of prevention. Clin Exp Allergy 30:1511\u20131518","journal-title":"Clin Exp Allergy"},{"key":"9_CR85","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1164\/rccm.2109018","volume":"166","author":"DI Bernstein","year":"2002","unstructured":"Bernstein DI, Cartier A, Cote J, Malo JL, Boulet LP, Wanner M, Milot J, L\u2019Archeveque J, Trudeau C, Lummus Z (2002) Diisocyanate antigen-stimulated monocyte chemoattractant protein-1 synthesis has greater test efficiency than specific antibodies for identification of diisocyanate asthma. Am J Respir Crit Care Med 166:445\u2013450","journal-title":"Am J Respir Crit Care Med"},{"key":"9_CR86","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0300-483X(96)03375-6","volume":"111","author":"JA Bernstein","year":"1996","unstructured":"Bernstein JA (1996) Overview of diisocyanate occupational asthma. Toxicology 111:181\u2013189","journal-title":"Toxicology"},{"key":"9_CR87","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0091-6749(89)90364-3","volume":"84","author":"A Cartier","year":"1989","unstructured":"Cartier A, Grammer L, Malo JL, Lagier F, Ghezzo H, Harris K, Patterson R (1989) Specific serum antibodies against isocyanates: association with occupational asthma. J Allergy Clin Immunol 84:507\u2013514","journal-title":"J Allergy Clin Immunol"},{"key":"9_CR88","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/ajrccm\/148.1.54","volume":"148","author":"LC Grammer","year":"1993","unstructured":"Grammer LC, Shaughnessy MA, Henderson J, Zeiss CR, Kavich DE, Collins MJ, Pecis KM, Kenamore BD (1993) A clinical and immunologic study of workers with trimellitic-anhydride-induced immunologic lung disease after transfer to low exposure jobs. Am Rev Respir Dis 148:54\u201357","journal-title":"Am Rev Respir Dis"},{"key":"9_CR89","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1378\/chest.114.4.1199","volume":"114","author":"L Grammer","year":"1998","unstructured":"Grammer L, Shaughnessy M, Kenamore B (1998) Utility of antibody in identifying individuals who have or will develop anhydride-induced respiratory disease. Chest 114:1199\u20131202","journal-title":"Chest"},{"key":"9_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1081-1206(10)61642-0","volume":"90","author":"X Baur","year":"2003","unstructured":"Baur X (2003) Are we closer to developing threshold limit values for allergens in the workplace? Ann Allergy Asthma Immunol 90:11\u201318","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9_CR91","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1164\/rccm.200311-1575SO","volume":"172","author":"CE Mapp","year":"2005","unstructured":"Mapp CE, Boschetto P, Maestrelli P, Fabbri LM (2005) Occupational asthma. Am J Respir Crit Care Med 172:280\u2013305","journal-title":"Am J Respir Crit Care Med"},{"key":"9_CR92","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0003-4878(00)00044-2","volume":"45","author":"D Heederik","year":"2001","unstructured":"Heederik D, Houba R (2001) An exploratory quantitative risk assessment for high molecular weight sensitizers: wheat flour. Ann Occup Hyg 45:175\u2013185","journal-title":"Ann Occup Hyg"},{"key":"9_CR93","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1201\/9781439832660.ch10","volume-title":"Proceedings of the 3rd World conference on detergents","author":"K Sarlo","year":"1994","unstructured":"Sarlo K (1994) Human health risk assessment: focus on enzymes. In: Cahn A (ed) Proceedings of the 3rd World conference on detergents. American Oil Chemists Society Press, Chicago, IL, pp 54\u201357"},{"key":"9_CR94","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tox.2004.12.010","volume":"209","author":"YJ Chung","year":"2005","unstructured":"Chung YJ, Coates NH, Viana ME, Copeland L, Vesper SJ, Selgrade MK, Ward MD (2005) Dose-dependent allergic responses to an extract of Penicillium chrysogenum in BALB\/c mice. Toxicology 209:77\u201389","journal-title":"Toxicology"},{"key":"9_CR95","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1600-0668.2010.00660.x","volume":"20","author":"MD Ward","year":"2010","unstructured":"Ward MD, Chung YJ, Copeland LB, Doerfler DL (2010) A comparison of the allergic responses induced by Penicillium chrysogenum and house dust mite extracts in a mouse model. Indoor Air 20:380\u2013391","journal-title":"Indoor Air"},{"key":"9_CR96","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0041-008X(83)90007-8","volume":"68","author":"MH Karol","year":"1983","unstructured":"Karol MH (1983) Concentration-dependent immunologic response to toluene diisocyanate (TDI) following inhalation exposure. Toxicol Appl Pharmacol 68:229\u2013241","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR97","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.toxlet.2005.09.006","volume":"161","author":"C Instanes","year":"2006","unstructured":"Instanes C, Ward MD, Hetland G (2006) The fungal biopesticide Metarhizium anisopliae has an adjuvant effect on the allergic response to ovalbumin in mice. Toxicol Lett 161:219\u2013225","journal-title":"Toxicol Lett"},{"key":"9_CR98","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/toxsci\/kfm194","volume":"100","author":"AK Farraj","year":"2007","unstructured":"Farraj AK, Boykin E, Haykal-Coates N, Gavett SH, Doerfler D, Selgrade M (2007) Th2 cytokines in skin draining lymph nodes and serum IgE do not predict airway hypersensitivity to intranasal isocyanate exposure in mice. Toxicol Sci 100:99\u2013108","journal-title":"Toxicol Sci"},{"key":"9_CR99","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfg171","volume":"75","author":"KJ Klink","year":"2003","unstructured":"Klink KJ, Meade BJ (2003) Dermal exposure to 3-amino-5-mercapto-1,2,4-triazole (AMT) induces sensitization and airway hyperreactivity in BALB\/c mice. Toxicol Sci 75:89\u201398","journal-title":"Toxicol Sci"},{"key":"9_CR100","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0300-483X(03)00338-X","volume":"194","author":"DM Sailstad","year":"2003","unstructured":"Sailstad DM, Ward MD, Boykin EH, Selgrade MK (2003) A murine model for low molecular weight chemicals: differentiation of respiratory sensitizers (TMA) from contact sensitizers (DNFB). Toxicology 194:147\u2013161","journal-title":"Toxicology"},{"key":"9_CR101","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s004200050328","volume":"72","author":"K Yokota","year":"1999","unstructured":"Yokota K, Johyama Y, Yamaguchi K, Takeshita T, Morimoto K (1999) Exposure-response relationships in rhinitis and conjunctivitis caused by methyltetrahydrophthalic anhydride. Int Arch Occup Environ Health 72:14\u201318","journal-title":"Int Arch Occup Environ Health"},{"key":"9_CR102","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1046\/j.1365-2222.1998.00276.x","volume":"28","author":"X Baur","year":"1998","unstructured":"Baur X, Chen Z, Liebers V (1998) Exposure-response relationships of occupational inhalative allergens. Clin Exp Allergy 28:537\u2013544","journal-title":"Clin Exp Allergy"},{"key":"9_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0300-483X(94)90167-8","volume":"92","author":"J Pauluhn","year":"1994","unstructured":"Pauluhn J, Mohr U (1994) Assessment of respiratory hypersensitivity in guinea-pigs sensitized to diphenylmethane-4,4\u2032-diisocyanate (MDI) and challenged with MDI, acetylcholine or MDI-albumin conjugate. Toxicology 92:53\u201374","journal-title":"Toxicology"},{"key":"9_CR104","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0378-4274(89)90083-0","volume":"47","author":"PA Botham","year":"1989","unstructured":"Botham PA, Rattray NJ, Woodcock DR, Walsh ST, Hext PM (1989) The induction of respiratory allergy in guinea-pigs following intradermal injection of trimellitic anhydride: a comparison with the response to 2,4-dinitrochlorobenzene. Toxicol Lett 47:25\u201339","journal-title":"Toxicol Lett"},{"key":"9_CR105","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1006\/taap.1998.8504","volume":"152","author":"JH Arts","year":"1998","unstructured":"Arts JH, Kuper CF, Spoor SM, Bloksma N (1998) Airway morphology and function of rats following dermal sensitization and respiratory challenge with low molecular weight chemicals. Toxicol Appl Pharmacol 152:66\u201376","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR106","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jaci.2003.11.047","volume":"113","author":"XD Zhang","year":"2004","unstructured":"Zhang XD, Fedan JS, Lewis DM, Siegel PD (2004) Asthmalike biphasic airway responses in Brown Norway rats sensitized by dermal exposure to dry trimellitic anhydride powder. J Allergy Clin Immunol 113:320\u2013326","journal-title":"J Allergy Clin Immunol"},{"key":"9_CR107","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.fct.2004.03.014","volume":"42","author":"JH Arts","year":"2004","unstructured":"Arts JH, Muijser H, Appel MJ, Frieke Kuper C, Bessems JG, Woutersen RA (2004) Subacute (28-day) toxicity of furfural in Fischer 344 rats: a comparison of the oral and inhalation route. Food Chem Toxicol 42:1389\u20131399","journal-title":"Food Chem Toxicol"},{"key":"9_CR108","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1021\/tx9003787","volume":"23","author":"KM Pollard","year":"2010","unstructured":"Pollard KM, Hultman P, Kono DH (2010) Toxicology of autoimmune diseases. Chem Res Toxicol 23:455\u2013466","journal-title":"Chem Res Toxicol"},{"issue":"Suppl 5","key":"9_CR109","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1289\/ehp.99107s5659","volume":"107","author":"J Heindel","year":"1999","unstructured":"Heindel J, Cooper GS, Germolec D, Selgrade M (1999) Linking environmental agents to autoimmune diseases. Environ Health Perspect 107(Suppl 5):659\u2013813","journal-title":"Environ Health Perspect"},{"key":"9_CR110","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0065-2776(07)95002-6","volume":"95","author":"M Carneiro-Sampaio","year":"2007","unstructured":"Carneiro-Sampaio M, Coutinho A (2007) Tolerance and autoimmunity: lessons at the bedside of primary immunodeficiencies. Adv Immunol 95:51\u201382","journal-title":"Adv Immunol"},{"key":"9_CR111","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.iac.2008.02.002","volume":"28","author":"TR Torgerson","year":"2008","unstructured":"Torgerson TR (2008) Immune dysregulation in primary immunodeficiency disorders. Immunol Allergy Clin North Am 28:315\u2013327","journal-title":"Immunol Allergy Clin North Am"},{"key":"9_CR112","volume-title":"The autoimmune diseases","author":"NR Rose","year":"2006","unstructured":"Rose NR, Mackay IR (2006) The autoimmune diseases. Elsevier, St. Louis, MO"},{"key":"9_CR113","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(16)59965-8","volume":"49","author":"KL Noller","year":"1988","unstructured":"Noller KL, Blair PB, O\u2019Brien PC, Melton LJ 3rd, Offord JR, Kaufman RH, Colton T (1988) Increased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol. Fertil Steril 49:1080\u20131082","journal-title":"Fertil Steril"},{"key":"9_CR114","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/0090-8258(83)90168-3","volume":"16","author":"CD Ford","year":"1983","unstructured":"Ford CD, Johnson GH, Smith WG (1983) Natural killer cells in in utero diethylstilbesterol-exposed patients. Gynecol Oncol 16:400\u2013404","journal-title":"Gynecol Oncol"},{"key":"9_CR115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0015-0282(16)59341-8","volume":"48","author":"SC Ways","year":"1987","unstructured":"Ways SC, Mortola JF, Zvaifler NJ, Weiss RJ, Yen SS (1987) Alterations in immune responsiveness in women exposed to diethylstilbestrol in utero. Fertil Steril 48:193\u2013197","journal-title":"Fertil Steril"},{"key":"9_CR116","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1067\/mob.2001.113873","volume":"185","author":"L Burke","year":"2001","unstructured":"Burke L, Segall-Blank M, Lorenzo C, Dynesius-Trentham R, Trentham D, Mortola JF (2001) Altered immune response in adult women exposed to diethylstilbestrol in utero. Am J Obstet Gynecol 185:78\u201381","journal-title":"Am J Obstet Gynecol"},{"key":"9_CR117","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/1529-0131(200002)43:2<243::AID-ANR2>3.0.CO;2-K","volume":"43","author":"FW Miller","year":"2000","unstructured":"Miller FW, Hess EV, Clauw DJ, Hertzman PA, Pincus T, Silver RM, Mayes MD, Varga J, Medsger TA Jr, Love LA (2000) Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 43:243\u2013249","journal-title":"Arthritis Rheum"},{"key":"9_CR118","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/15476910590960143","volume":"2","author":"R Patterson","year":"2005","unstructured":"Patterson R, Germolec D (2005) Toxic oil syndrome: review of immune aspects of the disease. J Immunotoxicol 2:51\u201358","journal-title":"J Immunotoxicol"},{"key":"9_CR119","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/00002281-199511000-00016","volume":"7","author":"LD Kaufman","year":"1995","unstructured":"Kaufman LD, Krupp LB (1995) Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol 7:560\u2013567","journal-title":"Curr Opin Rheumatol"},{"key":"9_CR120","first-page":"666","volume":"20","author":"EE Back","year":"1993","unstructured":"Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM (1993) Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York. J Rheumatol 20:666\u2013672","journal-title":"J Rheumatol"},{"key":"9_CR121","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jama.1992.03480010085029","volume":"267","author":"ML Kamb","year":"1992","unstructured":"Kamb ML, Murphy JJ, Jones JL, Caston JC, Nederlof K, Horney LF, Swygert LA, Falk H, Kilbourne EM (1992) Eosinophilia-myalgia syndrome in l-tryptophan-exposed patients. JAMA 267:77\u201382","journal-title":"JAMA"},{"key":"9_CR122","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0140-6736(81)90949-1","volume":"2","author":"JM Tabuenca","year":"1981","unstructured":"Tabuenca JM (1981) Toxic-allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 2:567\u2013568","journal-title":"Lancet"},{"issue":"Suppl 5","key":"9_CR123","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1289\/ehp.99107s5687","volume":"107","author":"SD Holladay","year":"1999","unstructured":"Holladay SD (1999) Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ Health Perspect 107(Suppl 5):687\u2013691","journal-title":"Environ Health Perspect"},{"key":"9_CR124","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/tera.1420440405","volume":"44","author":"SD Holladay","year":"1991","unstructured":"Holladay SD, Lindstrom P, Blaylock BL, Comment CE, Germolec DR, Heindell JJ, Luster MI (1991) Perinatal thymocyte antigen expression and postnatal immune development altered by gestational exposure to tetrachlorodibenzo-p-dioxin (TCDD). Teratology 44:385\u2013393","journal-title":"Teratology"},{"key":"9_CR125","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0041-008X(92)90189-Y","volume":"112","author":"BL Blaylock","year":"1992","unstructured":"Blaylock BL, Holladay SD, Comment CE, Heindel JJ, Luster MI (1992) Exposure to tetrachlorodibenzo-p-dioxin (TCDD) alters fetal thymocyte maturation. Toxicol Appl Pharmacol 112:207\u2013213","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR126","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/taap.1994.1114","volume":"126","author":"AE Silverstone","year":"1994","unstructured":"Silverstone AE, Frazier DE, Fiore NC, Soults JA, Gasiewicz TA (1994) Dexamethasone, \u03b2-estradiol, and 2,3,7,8-tetrachlorodibenzo-p-dioxin elicit thymic atrophy through different cellular targets. Toxicol Appl Pharmacol 126:248\u2013259","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR127","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/bdra.20603","volume":"85","author":"A Mustafa","year":"2009","unstructured":"Mustafa A, Holladay SD, Goff M, Witonsky S, Kerr R, Weinstein DA, Karpuzoglu-Belgin E, Gogal RM Jr (2009) Developmental exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters postnatal T cell phenotypes and T cell function and exacerbates autoimmune lupus in 24-week-old SNF1 mice. Birth Defects Res A Clin Mol Teratol 85:828\u2013836","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"9_CR128","first-page":"403","volume":"42","author":"AE Silverstone","year":"1998","unstructured":"Silverstone AE, Gavalchin J, Gasiewicz TA (1998) TCDD, DES, and estradiol potentiate a lupus-like autoimmune nephritis in NZB\u2009\u00d7\u2009SWR (SNF1) mice. Toxicologist 42:403","journal-title":"Toxicologist"},{"key":"9_CR129","first-page":"8","volume":"54","author":"DA Smith","year":"2000","unstructured":"Smith DA, Germolec DR (2000) Developmental exposure to TCDD and mercuric chloride in autoimmune-prone MRL\/lpr mice. Toxicologist 54:8","journal-title":"Toxicologist"},{"key":"9_CR130","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.taap.2008.04.015","volume":"232","author":"A Mustafa","year":"2008","unstructured":"Mustafa A, Holladay SD, Goff M, Witonsky SG, Kerr R, Reilly CM, Sponenberg DP, Gogal RM Jr (2008) An enhanced postnatal autoimmune profile in 24 week-old C57BL\/6 mice developmentally exposed to TCDD. Toxicol Appl Pharmacol 232:51\u201359","journal-title":"Toxicol Appl Pharmacol"},{"key":"9_CR131","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/3-540-27806-0_140","volume-title":"Encyclopedic reference of immunotoxicology","author":"DR Germolec","year":"2005","unstructured":"Germolec DR (2005) Autoimmune diseases, animal models. In: Vohr HW (ed) Encyclopedic reference of immunotoxicology. Springer, Berlin, Germany, pp 75\u201379"},{"key":"9_CR132","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0378-4274(01)00487-8","volume":"127","author":"R Pieters","year":"2002","unstructured":"Pieters R, Ezendam J, Bleumink R, Bol M, Nierkens S (2002) Predictive testing for autoimmunity. Toxicol Lett 127:83\u201391","journal-title":"Toxicol Lett"},{"key":"9_CR133","series-title":"Committee on the institutional means for assessment of risks to public health, Commission on life sciences","first-page":"1","volume-title":"Risk assessment in the federal government: managing the process","author":"NRC","year":"1983","unstructured":"NRC (1983) Risk assessment in the federal government: managing the process, Committee on the institutional means for assessment of risks to public health, Commission on life sciences. National Research Council, Washington DC, pp 1\u2013192"},{"key":"9_CR134","series-title":"Committee on risk assessment of hazardous air pollutants, Board on environmental studies and toxicology, Commission on life sciences","first-page":"1","volume-title":"Science and judgment in risk assessment","author":"NRC","year":"1994","unstructured":"NRC (1994) Science and judgment in risk assessment, Committee on risk assessment of hazardous air pollutants, Board on environmental studies and toxicology, Commission on life sciences. National Research Council, Washington DC, pp 1\u2013672"},{"key":"9_CR135","series-title":"IPCS environmental health criteria 210. International programme on chemical safety","volume-title":"Principles for the assessment of risks to human health from exposure to chemicals","author":"WHO","year":"1999","unstructured":"WHO (1999) Principles for the assessment of risks to human health from exposure to chemicals, IPCS environmental health criteria 210. International programme on chemical safety. World Health Organization, Geneva, Switzerland"},{"key":"9_CR136","first-page":"295","volume":"58","author":"AB Hill","year":"1965","unstructured":"Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295\u2013300","journal-title":"Proc R Soc Med"},{"key":"9_CR137","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1539-6924.2005.00699.x","volume":"25","author":"DL Weed","year":"2005","unstructured":"Weed DL (2005) Weight of evidence: a review of concept and methods. Risk Analysis 25:1545\u20131557","journal-title":"Risk Analysis"},{"key":"9_CR138","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1201\/9781420036817.sec3","volume-title":"Investigative immunotoxicology","author":"MI Luster","year":"2005","unstructured":"Luster MI, Germolec DR, Parks C, Blanciforti L, Kashon M, Luebke RW (2005) Associating changes in the immune system with clinical diseases for interpretation in risk assessment. In: Tryphonas H, Fournier M, Blakley BR, Smits JE, Brousseau P (eds) Investigative immunotoxicology. Taylor & Francis, New York, NY, pp 165\u2013182"},{"key":"9_CR139","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2174\/092986707780362899","volume":"14","author":"RR Dietert","year":"2007","unstructured":"Dietert RR, Dietert JM (2007) Early-life immune insult and developmental immunotoxicity (DIT)-associated diseases: potential of herbal- and fungal-derived medicinals. Curr Med Chem 14:1075\u20131085","journal-title":"Curr Med Chem"},{"key":"9_CR140","doi-asserted-by":"publisher","first-page":"192","DOI":"10.2741\/1521","volume":"10","author":"H Huang","year":"2005","unstructured":"Huang H, Patel D, Manton K (2005) The immune system in aging: roles of cytokines, T cells and NK cells. Front Biosci 10:192\u2013215","journal-title":"Front Biosci"},{"key":"9_CR141","first-page":"1","volume-title":"A review of the reference dose and reference concentration processes. Report","author":"U.S. EPA","year":"2002","unstructured":"U.S. EPA (2002) A review of the reference dose and reference concentration processes. Report. Risk Assessment Forum, Washington, DC, pp 1\u2013192"},{"key":"9_CR142","series-title":"IPCS environmental health criteria 239. International programme on chemical safety","volume-title":"Principles for modelling dose-response for the risk assessment of chemicals","author":"WHO","year":"2009","unstructured":"WHO (2009) Principles for modelling dose-response for the risk assessment of chemicals, IPCS environmental health criteria 239. International programme on chemical safety. World Health Organization, Geneva, Switzerland"},{"key":"9_CR143","first-page":"1","volume-title":"Use of the benchmark dose approach in health risk assessment. Report","author":"U.S. EPA","year":"1995","unstructured":"U.S. EPA (1995) Use of the benchmark dose approach in health risk assessment. Report. Risk Assessment Forum, Washington DC, pp 1\u201393"},{"key":"9_CR144","first-page":"1","volume-title":"Benchmark dose technical guidance document. External review draft. Report","author":"U.S. EPA","year":"2000","unstructured":"U.S. EPA (2000) Benchmark dose technical guidance document. External review draft. Report. Risk Assessment Forum, Washington DC, pp 1\u201396"},{"key":"9_CR145","series-title":"IPCS environmental health criteria 214. International programme on chemical safety","volume-title":"Human exposure assessment","author":"WHO","year":"2000","unstructured":"WHO (2000) Human exposure assessment, IPCS environmental health criteria 214. International programme on chemical safety. World Health Organization, Geneva, Switzerland"},{"key":"9_CR146","first-page":"1","volume-title":"Guidelines for exposure assessment. Report","author":"U.S. EPA","year":"1992","unstructured":"U.S. EPA (1992) Guidelines for exposure assessment. Report. Risk Assessment Forum, Washington DC, pp 1\u2013126"},{"key":"9_CR147","first-page":"1","volume-title":"Guidance on selecting age groups for monitoring and assessing childhood exposures to environmental contaminants. Report","author":"U.S. EPA","year":"2005","unstructured":"U.S. EPA (2005) Guidance on selecting age groups for monitoring and assessing childhood exposures to environmental contaminants. Report. Risk Assessment Forum, Washington DC, pp 1\u201350"},{"key":"9_CR148","volume-title":"Health effects test guidelines: OPPTS 870.7800 immunotoxicity. Report","author":"U.S. EPA","year":"1998","unstructured":"U.S. EPA (1998) Health effects test guidelines: OPPTS 870.7800 immunotoxicity. Report. Office of Prevention, Pesticides and Toxic Substances, Washington DC"},{"key":"9_CR149","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/15287390600591579","volume":"69","author":"MK Selgrade","year":"2006","unstructured":"Selgrade MK, Gilmour MI (2006) Immunotoxicology of inhaled compounds\u2015assessing risks of local immune suppression and hypersensitivity. J Toxicol Environ Health A 69:827\u2013844","journal-title":"J Toxicol Environ Health A"}],"container-title":["Experientia Supplementum","Molecular, Clinical and Environmental Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7643-8340-4_9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T13:53:38Z","timestamp":1787147618000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-7643-8340-4_9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9783764383398","9783764383404"],"references-count":148,"URL":"https:\/\/doi.org\/10.1007\/978-3-7643-8340-4_9","relation":{},"ISSN":["1023-294X"],"issn-type":[{"value":"1023-294X","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]},"assertion":[{"value":"24 April 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}